From Lignin to Value-Added Pharmaceutical Intermediates Based on a Benzylic Oxidation Method with O2

Org Lett. 2024 Jul 26;26(29):6076-6080. doi: 10.1021/acs.orglett.4c01608. Epub 2024 Jul 12.

Abstract

We present a catalytic strategy for converting lignin into various pharmaceutical intermediates based on a highly selective lignin depolymerization method and a green benzylic oxidation method employing O2. Selective depolymerization of lignin first afforded 4-ethylphenol, which then efficiently generates several pharmaceutical intermediates with a simple 5-step process, resulting in substantial economic benefits. The study provides an innovative solution for the efficient utilization of lignin and the green acquisition of pharmaceutical intermediates.